European journal of nuclear medicine and molecular imaging · 2024
Updated practice guideline for dual-energy X-ray absorptiometry (DXA).
СтатьяКлинические рекомендацииОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Slart Riemer H J A, Punda Marija, Ali Dalal S, Bazzocchi Alberto, Bock Oliver, Camacho Pauline, Carey John J, Colquhoun Anita, Compston Juliet, Engelke Klaus, Erba Paola A, Harvey Nicholas C, Krueger Diane, Lems Willem F, Lewiecki E Michael, Morgan Sarah, Moseley Kendall F, O'Brien Christopher, Probyn Linda, Rhee Yumie, Richmond Bradford, Schousboe John T, Shuhart Christopher, Ward Kate A, Van den Wyngaert Tim, Zhang-Yin Jules, Khan Aliya A, International Working Group on DXA Best Practices
Аннотация
The introduction of dual-energy X-ray absorptiometry (DXA) technology in the 1980s revolutionized the diagnosis, management and monitoring of osteoporosis, providing a clinical tool which is now available worldwide. However, DXA measurements are influenced by many technical factors, including the quality control procedures for the instrument, positioning of the patient, and approach to analysis. Reporting of DXA results may be confounded by factors such as selection of reference ranges for T-scores and Z-scores, as well as inadequate knowledge of current standards for interpretation. These points are addressed at length in many international guidelines but are not always easily assimilated by practising clinicians and technicians. Our aim in this report is to identify key elements pertaining to the use of DXA in clinical practice, considering both technical and clinical aspects. Here, we discuss technical aspects of DXA procedures, approaches to interpretation and integration into clinical practice, and the use of non-bone mineral density measurements, such as a vertebral fracture assessment, in clinical risk assessment.